PPARG and neoplasm: To characterize the effects of systemic PPARγ activation induced by pioglitazone on bone marrow cell recruitment and tumor progression, WT mice received bone marrow transplants from UBI-EGFP/B6 transgenic donors, which express EGFP in all cells.